市場調查報告書

核醫學/放射性醫藥品的全球市場 - 分析與預測:各用途(診斷、治療)、各終端用戶(醫院、診斷中心)、各地區

Nuclear Medicine/Radiopharmaceuticals Market to 2027 - Global Analysis and Forecasts by Applications (Diagnostic Applications, Therapeutic Applications); End User (Hospitals, Diagnostic Centers) and Geography

出版商 The Insight Partners 商品編碼 884699
出版日期 內容資訊 英文 185 Pages
訂單完成後即時交付
價格
核醫學/放射性醫藥品的全球市場 - 分析與預測:各用途(診斷、治療)、各終端用戶(醫院、診斷中心)、各地區 Nuclear Medicine/Radiopharmaceuticals Market to 2027 - Global Analysis and Forecasts by Applications (Diagnostic Applications, Therapeutic Applications); End User (Hospitals, Diagnostic Centers) and Geography
出版日期: 2019年06月14日內容資訊: 英文 185 Pages
簡介

本報告提供全球核醫學/放射性醫藥品市場調查分析,市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊彙整。

第1章 簡介

第2章 概要

第3章 調查方法

第4章 市場情況

  • 概要
  • PEST分析

第5章 市場趨勢

  • 推動市場的要素
  • 阻礙市場的要素
  • 市場機會
  • 現狀
  • 影響分析

第6章 全球市場分析

  • 收益預測與分析
  • 各地區市場
  • 主要企業的成果/定位

第7章 各用途市場分析分析

  • 概要
  • 各用途市場
  • 診斷
  • 治療

第8章 各終端用戶市場分析

  • 概要
  • 各終端用戶市場
  • 醫院
  • 診斷

第9章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區市場
  • 中東、非洲市場
  • 中南美市場

第10章 產業趨勢

  • 概要
  • 比較企業分析
  • 成長策略
  • 內部成長
  • 無機的成長

第11章 企業簡介

第12章 附錄

目錄
Product Code: TIPRE00003751

The global nuclear medicine/radiopharmaceuticals market is expected to reach US$ 6,683.99 Mn in 2027 from US$ 3,982.11 Mn in 2018. The market is estimated to grow with a CAGR of 6.2% from 2019-2027.

The market for nuclear medicine/radiopharmaceuticals is expected to grow, owing to factors such as rising prevalence of chronic diseases, alpha radioimmunotherapy-based targeted oncology treatment and advancement in imaging technologies using radiopharmaceuticals play vital role in the growth of the radiopharmaceuticals market. However, the restraints such as short shelf-life of radiopharmaceuticals and availability of substitutes of radiopharmaceuticals are likely to impact the growth of the market in the forecast period.

A radiopharmaceutical is a drug, which can be used either for diagnostic or therapeutic purposes. Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/ positron emission tomography (PET) cameras.

The shelf-life or expiry date of a radiopharmaceutical preparation depends mainly on the half-life of the radioisotope, the radiochemical stability and the content of longer-lived radionuclide impurities in the preparation under consideration. Most of the radiopharmaceutical preparations contain radioisotopes with very short half-lives and such preparations have very short shelf-lives. These preparations require an expiry date and time to be indicated. For example, technetium based preparations and positron emission tomography (PET) preparations are generally intended to be used within less than 12 hours, or sometimes within few minutes of preparation. Hence, the short shelf-life of radiopharmaceuticals are expected to hinder the growth of the market in the future years.

Global nuclear medicine/radiopharmaceuticals were segmented by application and end user. The application segment was segmented as diagnostic applications and therapeutic applications. Based on the end user, the market was segmented as hospitals and diagnostic centers. During 2018, the hospitals segment led the nuclear medicine/radiopharmaceuticals market by the end user.

Some of the major primary and secondary sources included in the report for, Society of Nuclear Medicine, Food and Drug Administration, American Cancer Society, World Health Organization, American Hospital Association (AHA), National Cancer Institute (NCI), Canadian Association of Nuclear Medicine, and others.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Market - By Applications
    • 1.3.2 Global Nuclear Medicine/Radiopharmaceuticals Market - By End User
    • 1.3.3 Global Nuclear Medicine/Radiopharmaceuticals Market - By Geography

2. Global Nuclear Medicine/Radiopharmaceuticals Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Nuclear Medicine/Radiopharmaceuticals Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis

5. Global Nuclear Medicine/Radiopharmaceuticals market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Chronic Diseases
    • 5.1.2 Alpha Radioimmunotherapy-Based Targeted Oncology Treatment
    • 5.1.3 Advancement in Imaging Technologies using Radiopharmaceuticals
  • 5.2 Key Market Restraints
    • 5.2.1 Short Shelf-Life of Radiopharmaceuticals
    • 5.2.2 Availability of Substitutes of Radiopharmaceuticals
  • 5.3 Key Market Opportunities
    • 5.3.1 Development in the Healthcare Market
    • 5.3.2 High Market Potential in Emerging Nations
  • 5.4 Current Trend
    • 5.4.1 Use of Nuclear Medicine For Personalized Treatment
  • 5.5 Impact Analysis

6. Nuclear Medicine/Radiopharmaceuticals Market - Global Analysis

  • 6.1 Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Forecasts and Analysis
  • 6.2 Global Nuclear Medicine/Radiopharmaceuticals Market, By Geography - Forecasts and Analysis
  • 6.3 Performance/ Positioning of Key Players
    • 6.3.1 Cardinal Health
    • 6.3.2 GENERAL ELECTRIC

7. Global Nuclear Medicine/Radiopharmaceuticals Market Analysis- by Applications

  • 7.1 Overview
  • 7.2 Global Nuclear Medicine/Radiopharmaceuticals Market BY applications, 2018 & 2027 (%)
  • 7.3 Diagnostic Applications Market
    • 7.3.1 Overview
    • 7.3.2 Global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.3 SPECT (Single-Photon Emission Computed Tomography) Applications Market
      • 7.3.3.1 Overview
      • 7.3.3.2 Global SPECT (Single-Photon Emission Computed Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.3.4 PET (Positron Emission Tomography) Applications Market
      • 7.3.4.1 Overview
      • 7.3.4.2 Global PET (Positron Emission Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)
  • 7.4 Therapeutic Applications Market
    • 7.4.1 Overview
    • 7.4.2 Global Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.3 Thyroid Market
      • 7.4.3.1 Overview
      • 7.4.3.2 Global Thyroid Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.4 Bone Metastasis Market
      • 7.4.4.1 Overview
      • 7.4.4.2 Global Bone Metastasis Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.5 Lymphoma Market
      • 7.4.5.1 Overview
      • 7.4.5.2 Global Lymphoma Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.6 Endocrine Tumors Market
      • 7.4.6.1 Overview
      • 7.4.6.2 Global Endocrine Tumors Market Revenue and Forecasts to 2027 (US$ Mn)
    • 7.4.7 Other Therapeutic Applications Market
      • 7.4.7.1 Overview
      • 7.4.7.2 Global Other Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

8. Global Nuclear Medicine/Radiopharmaceuticals Market Analysis- by End User

  • 8.1 Overview
  • 8.2 Global Nuclear Medicine/Radiopharmaceuticals Market, BY End User 2018 & 2027 (%)
  • 8.3 Hospitals market
    • 8.3.1 Overview
    • 8.3.2 Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • 8.4 Diagnostic Centers Market
    • 8.4.1 Overview
    • 8.4.2 Global Diagnostic Centers Market Revenue and Forecasts to 2025 (US$ Mn)

9. Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 9.1 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027
    • 9.1.1 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.2 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
      • 9.1.2.1 North America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.2.2 North America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.1.3 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.4 North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
    • 9.1.5 US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.1.6 US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.6.1 US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.1.6.1.1 US Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.1.6.1.2 US Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.6.2 US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.1.7 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.1 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.2 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.1.7.2.1 Canada Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.2.2 Canada Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.3 Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.1.7.4 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.5 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.1.7.6 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.1.7.6.1 Mexico Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.1.7.6.2 Mexico Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.1.7.7 Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.2 Europe Nuclear Medicine/Radiopharmaceuticals market Revenue and Forecasts to 2027
    • 9.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
      • 9.2.2.1 Europe Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.2.2 Europe Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.2.3 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
    • 9.2.5 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.5.1 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.5.2 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.2.5.2.1 UK Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.2.5.2.2 UK Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.5.3 UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.6 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.1 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.6.2 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.2.6.2.1 Germany Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.2.6.2.2 Germany Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.6.3 Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.7 France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.1 France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.7.2 France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.2.7.2.1 France Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.2.7.2.2 France Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.7.3 France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.8 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.8.1 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.8.2 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.2.8.2.1 Italy Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.2.8.2.2 Italy Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.8.3 Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.2.9 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.1 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.2.9.2 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.2.9.2.1 Spain Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.2.9.2.2 Spain Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.2.9.3 Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027
    • 9.3.1 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.3.2 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
      • 9.3.2.1 Asia Pacific Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.3.2.2 Asia Pacific Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.3.3 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.4 Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
    • 9.3.5 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.5.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.5.2 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.3.5.2.1 Japan Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.3.5.2.2 Japan Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.3.5.3 Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.6 China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.6.1 China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.6.2 China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.3.6.2.1 China Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.3.6.2.2 China Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.3.6.3 China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.7 India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.1 India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.2 India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.3.7.2.1 India Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.3.7.2.2 India Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.3.7.3 India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.3.7.4 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.5 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.7.6 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.3.7.6.1 South Korea Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.3.7.6.2 South Korea Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.3.7.7 South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.3.8 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.8.1 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.3.8.2 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.3.8.2.1 Australia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.3.8.2.2 Australia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.3.8.3 Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.4 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027
    • 9.4.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.4.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
      • 9.4.2.1 Middle East & Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.4.2.2 Middle East & Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • 9.5 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.5.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
    • 9.5.2 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.2.1 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.2.2 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.5.2.2.1 UAE Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.5.2.2.2 UAE Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.5.2.3 UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.5.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.3.1 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.3.2 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.5.3.2.1 Saudi Arabia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.5.3.2.2 Saudi Arabia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.5.3.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.5.4 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.4.1 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.5.4.2 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.5.4.2.1 South Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.5.4.2.2 South Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.5.4.3 South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
  • 9.6 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027
    • 9.6.1 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
    • 9.6.2 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
      • 9.6.2.1 South and Central America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.6.2.2 South and Central America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
    • 9.6.3 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.6.4 South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)
    • 9.6.5 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.6.5.1 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.6.5.2 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.6.5.2.1 Argentina Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.6.5.2.2 Argentina Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.6.5.3 Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)
    • 9.6.6 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.6.6.1 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
      • 9.6.6.2 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)
        • 9.6.6.2.1 Brazil Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 9.6.6.2.2 Brazil Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 9.6.6.3 Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10. Nuclear Medicine/Radiopharmaceuticals Market- Industry Landscape

  • 10.1 Overview
  • 10.2 Comparative Company Analysis
  • 10.3 Growth Strategies done by the companies in the Market, (%)
  • 10.4 Organic Developments
    • 10.4.1 Overview
  • 10.5 Inorganic developments
    • 10.5.1 Overview

11. Nuclear Medicine/Radiopharmaceuticals Market-Key Company Profiles

  • 11.1 Cardinal Health
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Financial Information
    • 11.1.4 Product Portfolio
    • 11.1.5 Swot Analysis
    • 11.1.6 Key Developments
  • 11.2 GENERAL ELECTRIC
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Financial Overview
    • 11.2.4 Product Portfolio
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 IBA Worldwide
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Financial Overview
    • 11.3.4 Product Portfolio
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Curium
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.1 Financial Information
    • 11.4.2 Product Portfolio
    • 11.4.3 SWOT Analysis
    • 11.4.4 Key Developments
  • 11.5 Positron Corporation
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Financial Overview
    • 11.5.4 Product Portfolio
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Lantheus Medical Imaging, Inc.
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Financial Information
    • 11.6.4 Product Portfolio
    • 11.6.5 Product Pipeline
    • 11.6.6 SWOT Analysis
    • 11.6.7 Key Developments
  • 11.7 NTP Radioisotopes SOC Ltd (Necsa)
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Financial Overview
    • 11.7.4 Product Portfolio
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 BAYER AG
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Financial Overview
    • 11.8.4 Product Portfolio
    • 11.8.5 Product Pipeline
    • 11.8.6 SWOT Analysis
    • 11.8.7 Key Developments
  • 11.9 Bracco
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Financial Overview
    • 11.9.4 Product Portfolio
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Advanced Accelerator Applications (Novartis AG)
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Financial Overview
    • 11.10.4 Product Portfolio
    • 11.10.5 Product Pipeline
    • 11.10.6 SWOT Analysis
    • 11.10.7 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

LIST OF TABLES

  • TABLE 1. Principal Radionuclides Used in Diagnostic Nuclear Medicine/Radiopharmaceuticals
  • TABLE 2. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 3. North America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 4. North America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 5. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 6. US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 7. US Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 8. US Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 9. US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 10. Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 11. Canada Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 12. Canada Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 13. Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 14. Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 15. Mexico Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 16. Mexico Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 17. Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 18. Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 19. Europe Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 20. Europe Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 21. Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 22. UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 23. UK Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 24. UK Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 25. UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 26. Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 27. Germany Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 28. Germany Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 29. Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 30. France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 31. France Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 32. France Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 33. France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 34. Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 35. Italy Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 36. Italy Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 37. Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 38. Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 39. Spain Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 40. Spain Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 41. Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 42. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 43. Asia Pacific Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 44. Asia Pacific Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 45. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 46. Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 47. Japan Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 48. Japan Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 49. Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 50. China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 51. China Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 52. China Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 53. China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 54. India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 55. India Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 56. India Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 57. India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 58. South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 59. South Korea Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 60. South Korea Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 61. South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 62. Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 63. Australia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 64. Australia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 65. Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 66. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 67. Middle East & Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 68. Middle East & Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 69. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 70. UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 71. UAE Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 72. UAE Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 73. UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 74. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 75. Saudi Arabia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 76. Saudi Arabia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 77. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 78. South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 79. South Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 80. South Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 81. South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 82. South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 83. South and Central America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 84. South and Central America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 85. South And Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 86. Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 87. Argentina Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 88. Argentina Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 89. Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 90. Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By applications (US$ Mn)
  • TABLE 91. Brazil Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 92. Brazil Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)
  • TABLE 93. Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By end user (US$ Mn)
  • TABLE 94. Organic Developments Done By Companies
  • TABLE 95. Inorganic Developments Done by Companies
  • TABLE 96. Glossary of Terms, Nuclear Medicine/Radiopharmaceuticals market

LIST OF FIGURES

  • FIGURE 1. Nuclear Medicine/Radiopharmaceuticals Market Segmentation
  • FIGURE 2. Nuclear Medicine/Radiopharmaceuticals Segmentation, by region
  • FIGURE 3. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market, Revenue (US$ Mn), By Geography 2018 & 2027
  • FIGURE 4. Global Nuclear Medicine/Radiopharmaceuticals Market By Applications Market Share (%), 2018
  • FIGURE 5. Global Nuclear Medicine/Radiopharmaceuticals Market By End User, Market Share (%), 2018
  • FIGURE 6. North America : PEST Analysis
  • FIGURE 7. Europe : PEST Analysis
  • FIGURE 8. Asia - Pacific : PEST Analysis
  • FIGURE 9. Middle East & Africa : PEST Analysis
  • FIGURE 10. South & Central America : PEST Analysis
  • FIGURE 11. Nuclear Medicine/Radiopharmaceuticals Market Impact Analysis of Drivers and Restraints
  • FIGURE 12. Global Nuclear Medicine/Radiopharmaceuticals Market - Revenue Forecasts and Analysis - 2019- 2027
  • FIGURE 13. Global Nuclear Medicine/Radiopharmaceuticals Market - by Geography Forecasts and Analysis - 2019- 2027
  • FIGURE 14. Market Positioning of Key Player in Global Nuclear Medicine/Radiopharmaceuticals Market
  • FIGURE 15. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications 2018 & 2027 (%)
  • FIGURE 16. Global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 17. Global SPECT (Single-Photon Emission Computed Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 18. Global PET (Positron Emission Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 19. Global Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 20. Global Thyroid Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 21. Global Bone Metastasis Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 22. Global Lymphoma Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 23. Global Endocrine Tumors Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 24. Global Other Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 25. Global Nuclear Medicine/Radiopharmaceuticals Market, by End User 2018 & 2027 (%)
  • FIGURE 26. Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 27. Global Diagnostic Centers Market Revenue and Forecasts to 2025 (US$ Mn)
  • FIGURE 28. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue, by Country, 2018 (US$ MN)
  • FIGURE 29. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 30. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
  • FIGURE 31. US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 32. Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 33. Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 34. Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue, by Country, 2018 (US$ MN)
  • FIGURE 35. Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 36. Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
  • FIGURE 37. UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 38. Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 39. France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 40. Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 41. Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 42. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country, 2018 (US$ MN)
  • FIGURE 43. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 44. Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
  • FIGURE 45. Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 46. China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 47. India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 48. South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 49. Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 50. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country, 2018 (US$ MN)
  • FIGURE 51. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 52. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
  • FIGURE 53. UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 54. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 55. South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 56. South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue, by Country, 2018 (US$ MN)
  • FIGURE 57. South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 58. South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)
  • FIGURE 59. Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 60. Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)
  • FIGURE 61. Comparative Company Analysis
  • FIGURE 62. Growth Strategies Done by the Companies in the Market, (%)